Cresset Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,644
| Closed | -$275K | – | 1742 |
|
|
2024
Q4 | $275K | Sell |
7,644
-23,808
| -76% | -$858K | ﹤0.01% | 1380 |
|
|
2024
Q3 | $1.33M | Buy |
31,452
+1,569
| +5% | +$66.5K | 0.01% | 997 |
|
|
2024
Q2 | $1.2M | Buy |
29,883
+1,697
| +6% | +$68.4K | 0.01% | 944 |
|
|
2024
Q1 | $998K | Buy |
28,186
+10,586
| +60% | +$375K | ﹤0.01% | 965 |
|
|
2023
Q4 | $521K | Buy |
+17,600
| New | +$521K | ﹤0.01% | 1191 |
|
|
2022
Q4 | – | Sell |
-7,460
| Closed | -$403K | – | 885 |
|
|
2022
Q3 | $403K | Sell |
7,460
-40
| -0.5% | -$2.16K | 0.01% | 573 |
|
|
2022
Q2 | $444K | Buy |
7,500
+671
| +10% | +$39.7K | 0.01% | 597 |
|
|
2022
Q1 | $794K | Sell |
6,829
-410
| -6% | -$47.7K | 0.01% | 465 |
|
|
2021
Q4 | $1.09M | Buy |
7,239
+1,239
| +21% | +$187K | 0.01% | 430 |
|
|
2021
Q3 | $716K | Hold |
6,000
| – | – | 0.01% | 498 |
|
|
2021
Q2 | $584K | Buy |
+6,000
| New | +$584K | 0.01% | 513 |
|